Case number 1:21-cv-00530
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Lupin Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 18, 2022 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:20-cv-01153-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 20-1153-CFC ONLY. (nmf) |
| Apr 18, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Civil Action No. 20-1153-CFC and Civil Action No. 21-530-CFC are consolidated for all purposes. All future filings shall be made in Lead Case No. 20-1153-CFC only. Ordered by Judge Colm F. Connolly on 4/18/2022. (nmf) |
| Apr 13, 2022 | N/A | Status Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - In-Person Status Conference held on 4/13/2022. (Court Reporter Bonnie Archer.) Associated Cases: 1:18-cv-01689-CFC-SRF et al.(nmf) |
| Apr 7, 2022 | 29 | Motion for Leave to Appear Pro Hac Vice (12) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales, Jeanna M. Wacker, Sam Kwon, and Ashley Ross - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Apr 7, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (19 in 1:21-cv-01486-CFC, 29 in 1:21-cv-00530-CFC, 11 in 1:22-cv-00220-CFC, 21 in 1:21-cv-01766-CFC, 19 in 1:21-cv-01573-CFC, 19 in 1:21-cv-01485-CFC, 19 in 1:21-cv-01487-CFC) MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales, Jeanna M. Wacker, Sam Kwon, and Ashley Ross, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Ordered by Judge Colm F. Connolly on 4/7/2022. Associated Cases: 1:21-cv-00530-CFC et al.(kmd) |
| Apr 5, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER Re-Setting Hearings, Due to a conflict in the Court's schedule, the In-Person Status Conference to discuss the parties' letters is rescheduled for 4/13/2022 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 4/5/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf) |
| Apr 1, 2022 | 28 | Order (4) Docket Text: ORDER, Setting Hearings: A Status Conference is set for 4/13/2022 at 11:00 AM in Courtroom 4B before Judge Colm F. Connolly to discuss the parties' letters. Signed by Judge Colm F. Connolly on 4/1/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf) |
| Mar 21, 2022 | 27 | Answer to Counterclaim (30) Docket Text: ANSWER to [21] Answer to Complaint, Counterclaim -- Answer to Counterclaims -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Mar 17, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of the 3/15/2022 Letter to Honorable Colm F. Connolly from Megan E. Dellinger regarding response to Defendants March 11, 2022 letter has been replaced with a corrected version in order to to correct an error in the table on page 2 with respect to the answer date for defendant Laurus in the 22-220 action per request of filer. Associated Cases: 1:21-cv-00530-CFC et al.(nmf) |
| Mar 15, 2022 | 26 | Letter (4) Docket Text: Letter to Honorable Colm F. Connolly from Megan E. Dellinger regarding response to Defendants March 11, 2022 letter - re (25 in 1:21-cv-00530-CFC) Letter. (Dellinger, Megan) (Main Document 26 replaced on 3/17/2022) (nmf, ). |
| Mar 11, 2022 | 25 | Letter (4) Docket Text: Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding case management issues. (Phillips, John) |
| Mar 8, 2022 | 24 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding coordinated discovery and Markman - re (11 in 1:21-cv-01487-CFC, 11 in 1:21-cv-01487-CFC, 19 in 1:21-cv-00530-CFC, 19 in 1:21-cv-00530-CFC, 11 in 1:21-cv-01766-CFC, 11 in 1:21-cv-01766-CFC, 11 in 1:21-cv-01486-CFC, 11 in 1:21-cv-01486-CFC, 13 in 1:21-cv-01485-CFC, 13 in 1:21-cv-01485-CFC) Order,, Set Deadlines,. (Dellinger, Megan) |
| Mar 1, 2022 | 23 | Certification of Kevin J. Boyle (1) |
| Mar 1, 2022 | 23 | Certification of Kurt A. Mathas (1) |
| Mar 1, 2022 | 23 | Certification of Michael K. Nutter (1) |
| Mar 1, 2022 | 23 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael K. Nutter, Kurt A. Mathas and Kevin J. Boyle - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Attachments: # (1) Certification of Michael K. Nutter, # (2) Certification of Kurt A. Mathas, # (3) Certification of Kevin J. Boyle)(Bilson, David) |
| Mar 1, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael K. Nutter,Kurt A. Mathas,Kevin J. Boyle for Lupin Ltd. and Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
| Mar 1, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [23] MOTION for Pro Hac Vice Appearance of Attorney Michael K. Nutter, Kurt A. Mathas and Kevin J. Boyle, filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 3/1/2022. (kmd) |
| Feb 28, 2022 | 22 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Ltd. for Lupin Pharmaceuticals, Inc. filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Feb 28, 2022 | 21 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Phillips, John) |
| Feb 15, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [20] STIPULATION TO EXTEND TIME for Lupin to answer, plead or otherwise respond to the Complaint (D.I. 1) to February 28, 2022, filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Reset Answer Deadlines: Lupin Ltd. answer due 2/28/2022; Lupin Pharmaceuticals, Inc. answer due 2/28/2022. Ordered by Judge Colm F. Connolly on 2/15/2022. (kmd) |
| Feb 14, 2022 | 20 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Lupin to answer, plead or otherwise respond to the Complaint (D.I. 1) to February 28, 2022 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Bilson, David) |
| Feb 8, 2022 | 19 | Order (4) Docket Text: ORDER: IT IS ORDERED that, on or before March 8, 2022, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 3/8/2022.) Signed by Judge Colm F. Connolly on 2/7/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf) |
| Jan 13, 2022 | 18 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Lupin Ltd. and Lupin Pharmaceuticals, Inc. to answer, plead or otherwise respond to the Complaint (D.I. 1) to February 14, 2022 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Bilson, David) |
| Jan 13, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [18] STIPULATION TO EXTEND TIME for Lupin Ltd. and Lupin Pharmaceuticals, Inc. to answer, plead or otherwise respond to the Complaint (D.I. 1) to February 14, 2022, filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Reset Answer Deadlines: Lupin Ltd. answer due 2/14/2022; Lupin Pharmaceuticals, Inc. answer due 2/14/2022. Ordered by Judge Colm F. Connolly on 1/13/2022. (kmd) |
| Dec 15, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [17] STIPULATION TO EXTEND TIME for Lupin to answer, plead or otherwise respond to the Complaint (D.I. 1) to January 14, 2022, filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Reset Answer Deadlines: Lupin Ltd. answer due 1/14/2022; Lupin Pharmaceuticals, Inc. answer due 1/14/2022. Ordered by Judge Colm F. Connolly on 12/15/2021. (kmd) |
| Dec 15, 2021 | 17 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Lupin to answer, plead or otherwise respond to the Complaint (D.I. 1) to January 14, 2022 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Bilson, David) |
| Nov 15, 2021 | 16 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc. to answer plead or otherwise respond to the Complaint (D.I. 1) to December 15, 2021 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Bilson, David) |
| Nov 15, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] STIPULATION TO EXTEND TIME for defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc. to answer plead or otherwise respond to the Complaint (D.I. 1) to December 15, 2021, filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Reset Answer Deadlines: Lupin Ltd. answer due 12/15/2021; Lupin Pharmaceuticals, Inc. answer due 12/15/2021. Ordered by Judge Colm F. Connolly on 11/15/2021. (kmd) |
| Oct 14, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] STIPULATION TO EXTEND TIME deadline for Lupin to answer, plead or otherwise respond to the Complaint to November 15, 2021 filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Set/Reset Answer Deadlines: Lupin Ltd. answer due 11/15/2021; Lupin Pharmaceuticals, Inc. answer due 11/15/2021. Ordered by Judge Colm F. Connolly on 10/14/2021. (kmd) |
| Oct 13, 2021 | 15 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME deadline for Lupin to answer, plead or otherwise respond to the Complaint to November 15, 2021 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Bilson, David) |
| Sep 16, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] STIPULATION TO EXTEND TIME for Lupin to answer, plead or otherwise respond to the Complaint (D.I. 1) to October 15, 2021 filed by Lupin Ltd., Lupin Pharmaceuticals, Inc., Set/Reset Answer Deadlines: Lupin Ltd. answer due 10/15/2021; Lupin Pharmaceuticals, Inc. answer due 10/15/2021. Signed by Judge Colm F. Connolly on 9/16/2021. (nmf) |
| Sep 15, 2021 | 14 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Lupin to answer, plead or otherwise respond to the Complaint (D.I. 1) to October 15, 2021 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Bilson, David) |
| Aug 17, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] STIPULATION TO EXTEND TIME for defendant to answer, plead or otherwise respond to the Complaint to September 15, 2021 filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Set/Reset Answer Deadlines: Lupin Ltd. answer due 9/15/2021; Lupin Pharmaceuticals, Inc. answer due 9/15/2021. Signed by Judge Colm F. Connolly on 8/17/2021. (fms) |
| Aug 16, 2021 | 13 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for defendant to answer, plead or otherwise respond to the Complaint to September 15, 2021 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Bilson, David) |
| Jul 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] STIPULATION TO EXTEND TIME for Lupin to answer, plead or otherwise respond to the Complaint (D.I. 1) to August 16, 2021 filed by Lupin Ltd., Lupin Pharmaceuticals, Inc., Set/Reset Answer Deadlines: Lupin Ltd. answer due 8/16/2021; Lupin Pharmaceuticals, Inc. answer due 8/16/2021. Signed by Judge Colm F. Connolly on 7/19/2021. (fms) |
| Jul 15, 2021 | 12 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Lupin to answer, plead or otherwise respond to the Complaint (D.I. 1) to August 16, 2021 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Bilson, David) |
| Jun 25, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] STIPULATION TO EXTEND TIME to answer, plead or otherwise respond to the Complaint to July 15, 2021 filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Set/Reset Answer Deadlines: Lupin Ltd. answer due 7/15/2021; Lupin Pharmaceuticals, Inc. answer due 7/15/2021. Signed by Judge Colm F. Connolly on 6/25/2021. (fms) |
| Jun 24, 2021 | 11 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, plead or otherwise respond to the Complaint to July 15, 2021 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Jun 7, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] STIPULATION TO EXTEND TIME to answer, plead or otherwise respond to the Complaint to June 24, 2021 filed by Lupin Ltd., Lupin Pharmaceuticals, Inc., Set/Reset Answer Deadlines: Lupin Ltd. answer due 6/24/2021; Lupin Pharmaceuticals, Inc. answer due 6/24/2021. Signed by Judge Colm F. Connolly on 6/7/2021. (fms) |
| Jun 4, 2021 | 10 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, plead or otherwise respond to the Complaint to June 24, 2021 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| May 5, 2021 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for defendants to respond to the Complaint to June 10, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| May 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION TO EXTEND TIME for defendants to respond to the Complaint to June 10, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Set/Reset Answer Deadlines: Lupin Ltd. answer due 6/10/2021; Lupin Pharmaceuticals, Inc. answer due 6/10/2021. Signed by Judge Colm F. Connolly on 5/5/2021. (fms) |
| Apr 21, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Apr 19, 2021 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Lupin Pharmaceuticals, Inc. served on 4/19/2021, answer due 5/10/2021. (Dellinger, Megan) |
| Apr 19, 2021 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Lupin Ltd. served on 4/19/2021, answer due 5/10/2021. (Dellinger, Megan) |
| Apr 13, 2021 | 1 | Main Document (25) Docket Text: COMPLAINT filed against Lupin Ltd., Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3592448.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # (1) Exhibit 1-7, # (2) Civil Cover Sheet)(apk) |
| Apr 13, 2021 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (apk) |
| Apr 13, 2021 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C.H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.(apk) |
| Apr 13, 2021 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,551,957 B2 ;9,155,705 B2 ;9,415,016 B2 ;9,949,998 B2 ;10,022,379 B2 ;10,258,637 B2 ;10,406,172 B2. (apk) |
| Apr 13, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/4/2021. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 9/4/2023. (apk) |
| Apr 13, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Apr 13, 2021 | 1 | Civil Cover Sheet (1) |
| Apr 13, 2021 | 1 | Exhibit 1-7 (272) |
| Apr 13, 2021 | 1 | Complaint* (1) |
